Clinical Trial Update: Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating the safety and effectiveness of the PXL Platinum 330 System with riboflavin solution for refractory corneal ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ulcer
• Keratitis

Drugs mentioned

• PXL Platinum 330 System
• Riboflavin solution (Riboflavin)

Snippet

Sponsor: Peschke GmbH | Conditions: Keratitis, Corneal Ulcer | Phase 2, Phase 3 | Status: UNKNOWN